Business Parks & Science Centres



Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

Oxford Nanopore Technologies Ltd.. (2/24/16). "Press Release: Response to Litigation".

Organisations Organisation Oxford Nanopore Technologies Ltd.
  Group Oxford Nanopore (Group)
  Organisation 2 Illumina Inc. (Nasdaq: ILMN)
  Group Illumina (Group)
Products Product nanopore technology
  Product 2 MinION™ sequencing system
  Index term 2 Oxford Nanopore–Illumina: investment, 201311 DIVESTMENT of Illumina’s 13.5% shareholding for £56.4m to other investors
Person Person Sanghera, Gordon (Oxford NanoLabs 200506 CEO)

Oxford Nanopore Technologies, the UK-based company that sells the only nanopore sequencing device, the MinION portable DNA sequencer and is developing the high throughput/ high sample number PromethION device, responds to the patent lawsuit filed by Illumina, Inc. 

Dr Gordon Sanghera, CEO of Oxford Nanopore said “It is gratifying to have the commercial relevance of Oxford Nanopore products so publicly acknowledged by the market monopolist for NGS.”
We do not anticipate any disruption to our ongoing commercial progress as a result of Illumina’s action, which we believe is without merit.

Record changed: 2016-02-27


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Oxford Nanopore (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

» top